This inventor holds 1 USPTO granted patent. Top assignee: Gilead Sciences, Inc.. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Amoreena Corsa: Innovator in Hepatitis C Research
Introduction
Amoreena Corsa is a prominent inventor based in San Francisco, CA. She has made significant contributions to the field of virology, particularly in the study of hepatitis C virus (HCV). Her innovative work has led to advancements in understanding and combating this viral infection.
Latest Patents
Amoreena holds a patent for "HCV genotype 3 replicons." This patent describes replicons of genotype 3 of hepatitis C virus, which contain adaptive mutations that enhance the virus's capability to replicate in vitro. The patent also outlines methods for preparing these genotype 3 replicons and their use in screening antiviral agents.
Career Highlights
Amoreena is currently employed at Gilead Sciences, Inc., a leading biopharmaceutical company. Her work at Gilead focuses on developing therapies for viral infections, contributing to the company's mission of improving patient outcomes through innovative treatments.
Collaborations
Amoreena has collaborated with notable colleagues, including William E. Delaney, IV, and Guofeng Cheng. These collaborations have fostered a productive research environment, leading to significant advancements in their shared field of study.
Conclusion
Amoreena Corsa's contributions to hepatitis C research exemplify her dedication to innovation in the medical field. Her patent and work at Gilead Sciences, Inc. highlight her role as a key player in the fight against viral infections.